<bill session="115" type="s" number="2003" updated="2019-11-15T22:00:20Z">
  <state datetime="2017-10-25">REFERRED</state>
  <status>
    <introduced datetime="2017-10-25"/>
  </status>
  <introduced datetime="2017-10-25"/>
  <titles>
    <title type="official" as="introduced">A bill to modernize the regulation of cosmetics.</title>
    <title type="short" as="introduced">FDA Cosmetic Safety and Modernization Act</title>
    <title type="short" as="introduced">FDA Cosmetic Safety and Modernization Act</title>
    <title type="display">FDA Cosmetic Safety and Modernization Act</title>
  </titles>
  <sponsor bioguide_id="H000338"/>
  <cosponsors/>
  <actions>
    <action datetime="2017-10-25">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-10-25" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2017-10-25T04:00:00Z" status="Introduced in Senate">FDA Cosmetic Safety and Modernization Act

This bill establishes a series of requirements relating to cosmetics regulation, including requiring cosmetics manufacturers and distributors to report serious adverse health events to the Food and Drug Administration.</summary>
  <committee-reports/>
</bill>
